Ratings Summary for METHOTREXATE SODIUM

Overall Patient opinion of METHOTREXATE SODIUM: 3.3 (satisfied)

(based on 383 reviews ) (updated May 6, 2025)

Ratings by Age Group for METHOTREXATE SODIUM
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)	7	3
Age 18 to 24	34	2.9
Age 25 to 34	68	2.9
Age 35 to 44	101	3.3
Age 45 to 54	102	3.5
Age 55 to 64	44	3.2
Age 65 to 74	18	3.7
Age 75 and up	3	1.6

Ratings by Sex for METHOTREXATE SODIUM
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	100	3.46
Female	275	3.35272727272727
Not Specified	8	3

Would you like to find reviews for METHOTREXATE SODIUM taken for a specific reason or resulting in a specific side effect?

Filter Results for METHOTREXATE SODIUM

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for METHOTREXATE SODIUM

Check here for Ask a Patient's Adverse Event Summary for METHOTREXATE SODIUM based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

METHOTREXATE SODIUM (METHOTREXATE SODIUM): Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. FDA Approval Date: 1953-01-01 (Sources: U.S. Centers for Medicare Services, FDA)